Skip to main content
E

Elidah

Elidah provides Elitone, an FDA‑cleared wearable device that delivers low‑level electrical stimulation to strengthen the pelvic floor and reduce stress and urge urinary incontinence. The adhesive‑backed unit is worn discreetly under clothing for a 20‑minute daily session and is sold prescription‑free through an online storefront, with optional clinician portals for treatment guidance and outcome tracking.

Newtown, United StatesFounded 20157700+ followers
Updated 3 months ago

Funding

Funding not disclosed

BV
Funding rounds are not available yet.

Founders

Product

Problem

Many women experience stress or urge urinary incontinence, relying on disposable pads or invasive procedures that are uncomfortable, costly, and limit daily activities. Limited access to discreet, at‑home treatment options leads to reduced quality of life and ongoing health concerns.

Solution

Elidah offers Elitone®, an FDA‑cleared external pelvic floor therapy device that delivers low‑level neuromuscular stimulation to strengthen the pelvic floor. The lightweight unit adheres gently to the skin and is worn under clothing for a 20‑minute daily session, allowing users to treat leaks without pads, catheters, or clinical visits. The system is available without a prescription and ships directly to the consumer, enabling immediate start of therapy. Clinical data show that 95 % of users experience improvement, with an average daily leak reduction of over 70 %. Elitone also supports a dedicated version for urge incontinence (Elitone URGE) and provides clinicians with educational resources to integrate the device into standard care pathways.

Target Audience

Primary customers are women experiencing stress or urge urinary incontinence who seek a non‑invasive, at‑home solution, as well as urologists, urogynecologists, and pelvic floor therapists who incorporate device‑based therapy into their practice.

Features

  • Wearable, adhesive‑backed device that fits discreetly under clothing and operates hands‑free for 20 minutes per day
  • Low‑level electrical stimulation protocol optimized for both stress and urge urinary incontinence (Elitone & Elitone URGE)
  • FDA‑cleared, clinically validated efficacy (95 % improvement, >70 % leak reduction)
  • Prescription‑free e‑commerce distribution with direct‑to‑home shipping for immediate use
  • Simple “peel, press, go” activation eliminates the need for trained operators or clinic appointments
  • Integrated clinician portal offering treatment guidelines, patient education, and outcome tracking tools
  • HIPAA‑compliant data handling for optional remote monitoring and reporting
  • Scalable platform with potential extensions to male stress incontinence and pelvic pain applications
This profile is AI-generated and may contain inaccuracies.